|
2024-02-20 |
2024-02-16 |
S
Sale
|
Kelly Thomas Patrick
Chief Financial Officer
Officer
|
3,010
-3.6%
15.62
47,009
USD
|
3,010
-3.6%
|
15.62
|
47,009
USD
|
|
|
2024-02-20 |
2024-02-16 |
S
Sale
|
Sherman Matthew L
EVP & Chief Medical Officer
Officer
|
2,615
-2.3%
15.62
40,840
USD
|
2,615
-2.3%
|
15.62
|
40,840
USD
|
|
|
2024-02-20 |
2024-02-16 |
S
Sale
|
Pitman Jama
SVP, Chief Development Officer
Officer
|
2,267
-3.2%
15.62
35,405
USD
|
2,267
-3.2%
|
15.62
|
35,405
USD
|
|
|
2024-02-20 |
2024-02-16 |
S
Sale
|
Martin Daniel C.
Chief Commercial Officer
Officer
|
2,267
-4.0%
15.62
35,405
USD
|
2,267
-4.0%
|
15.62
|
35,405
USD
|
|
|
2024-01-18 |
2024-01-16 |
S
Sale
|
Pitman Jama
SVP, Chief Development Officer
Officer
|
1,624
-3.1%
14.47
23,499
USD
|
1,624
-3.1%
|
14.47
|
23,499
USD
|
|
|
2024-01-18 |
2024-01-16 |
S
Sale
|
Sherman Matthew L
EVP & Chief Medical Officer
Officer
|
2,435
-2.5%
14.47
35,234
USD
|
2,435
-2.5%
|
14.47
|
35,234
USD
|
|
|
2024-01-18 |
2024-01-16 |
S
Sale
|
Kelly Thomas Patrick
Chief Financial Officer
Officer
|
2,435
-3.6%
14.47
35,234
USD
|
2,435
-3.6%
|
14.47
|
35,234
USD
|
|
|
2024-01-18 |
2024-01-16 |
S
Sale
|
Martin Daniel C.
Chief Commercial Officer
Officer
|
1,624
-3.3%
14.47
23,499
USD
|
1,624
-3.3%
|
14.47
|
23,499
USD
|
|
|
2023-12-14 |
2023-12-13 |
S
Sale
|
Kelly Thomas Patrick
Chief Financial Officer
Officer
|
2,792
-3.9%
15.37
42,905
USD
|
2,792
-3.9%
|
15.37
|
42,905
USD
|
|
|
2023-12-14 |
2023-12-13 |
S
Sale
|
Sherman Matthew L
EVP & Chief Medical Officer
Officer
|
2,792
-2.8%
15.37
42,905
USD
|
2,792
-2.8%
|
15.37
|
42,905
USD
|
|
|
2023-12-14 |
2023-12-13 |
S
Sale
|
Pitman Jama
See Remarks
Officer
|
1,662
-3.1%
15.37
25,540
USD
|
1,662
-3.1%
|
15.37
|
25,540
USD
|
|
|
2023-12-14 |
2023-12-13 |
S
Sale
|
Hoerter Steven L.
President and CEO
Executive Director
|
30,664
-29.6%
15.37
471,217
USD
|
30,664
-29.6%
|
15.37
|
471,217
USD
|
|
|
2023-12-14 |
2023-12-13 |
S
Sale
|
Martin Daniel C.
Chief Commercial Officer
Officer
|
1,727
-3.4%
15.37
26,539
USD
|
1,727
-3.4%
|
15.37
|
26,539
USD
|
|
|
2023-12-01 |
2023-11-30 |
PS
Planned sale
|
Martin Daniel C.
Chief Commercial Officer
Officer
|
17,801
-28.2%
12.57
223,755
USD
|
17,801
-28.2%
|
12.57
|
223,755
USD
|
|
|
2023-10-31 |
2023-10-30 |
S
Sale
|
Martin Daniel C.
Chief Commercial Officer
Officer
|
1,407
-2.2%
12.02
16,909
USD
|
1,407
-2.2%
|
12.02
|
16,909
USD
|
|
|
2023-10-31 |
2023-10-30 |
S
Sale
|
Hoerter Steven L.
President and CEO
Executive Director
|
21,573
-34.5%
12.02
259,256
USD
|
21,573
-34.5%
|
12.02
|
259,256
USD
|
|
|
2023-10-31 |
2023-10-30 |
S
Sale
|
Pitman Jama
See Remarks
Officer
|
1,407
-2.8%
12.02
16,909
USD
|
1,407
-2.8%
|
12.02
|
16,909
USD
|
|
|
2023-10-31 |
2023-10-30 |
S
Sale
|
Sherman Matthew L
EVP & Chief Medical Officer
Officer
|
2,360
-2.5%
12.02
28,362
USD
|
2,360
-2.5%
|
12.02
|
28,362
USD
|
|
|
2023-10-31 |
2023-10-30 |
S
Sale
|
Kelly Thomas Patrick
Chief Financial Officer
Officer
|
2,316
-3.5%
12.02
27,833
USD
|
2,316
-3.5%
|
12.02
|
27,833
USD
|
|
|
2023-10-04 |
2023-10-02 |
S
Sale
|
Sherman Matthew L
EVP & Chief Medical Officer
Officer
|
2,942
-3.4%
12.68
37,305
USD
|
2,942
-3.4%
|
12.68
|
37,305
USD
|
|
|
2023-06-21 |
2023-06-16 |
S
Sale
|
Kelly Thomas Patrick
Chief Financial Officer
Officer
|
1,655
-2.8%
14.40
23,835
USD
|
1,655
-2.8%
|
14.40
|
23,835
USD
|
|
|
2023-06-21 |
2023-06-16 |
PS
Planned sale
|
Martin Daniel C.
Chief Commercial Officer
Officer
|
1,238
-2.1%
14.40
17,829
USD
|
1,238
-2.1%
|
14.40
|
17,829
USD
|
|
|
2023-06-21 |
2023-06-16 |
PS
Planned sale
|
Sherman Matthew L
EVP & Chief Medical Officer
Officer
|
1,655
-1.9%
14.40
23,835
USD
|
1,655
-1.9%
|
14.40
|
23,835
USD
|
|
|
2023-06-21 |
2023-06-16 |
S
Sale
|
Flynn Daniel Lee
Chief Scientific Officer
Officer
|
1,655
-2.8%
14.40
23,835
USD
|
1,655
-2.8%
|
14.40
|
23,835
USD
|
|
|
2023-06-21 |
2023-06-16 |
S
Sale
|
Pitman Jama
See Remarks
Officer
|
1,238
-2.7%
14.40
17,829
USD
|
1,238
-2.7%
|
14.40
|
17,829
USD
|
|
|
2023-06-12 |
2023-06-08 |
B
Purchase
|
Friedman Franklin Stuart
Non-Executive Director
|
10,000
+inf%
13.88
138,828
USD
|
10,000
+inf%
|
13.88
|
138,828
USD
|
|
|
2023-05-12 |
2023-05-10 |
B
Purchase
|
Walsh Dennis Leo
Non-Executive Director
|
11,000
+inf%
13.86
152,416
USD
|
11,000
+inf%
|
13.86
|
152,416
USD
|
|
|
2023-03-23 |
2023-03-21 |
PS
Planned sale
|
Hoerter Steven L.
President and CEO
Executive Director
|
7,500
-100.0%
15.57
116,782
USD
|
7,500
-100.0%
|
15.57
|
116,782
USD
|
|
|
2023-02-17 |
2023-02-16 |
S
Sale
|
Martin Daniel C.
Chief Commercial Officer
Officer
|
1,159
-1.9%
15.10
17,500
USD
|
1,159
-1.9%
|
15.10
|
17,500
USD
|
|
|
2023-02-17 |
2023-02-16 |
S
Sale
|
Kelly Thomas Patrick
Chief Financial Officer
Officer
|
1,370
-2.3%
15.10
20,686
USD
|
1,370
-2.3%
|
15.10
|
20,686
USD
|
|
|
2023-02-17 |
2023-02-16 |
S
Sale
|
Flynn Daniel Lee
Chief Scientific Officer
Officer
|
1,370
-2.3%
15.10
20,686
USD
|
1,370
-2.3%
|
15.10
|
20,686
USD
|
|
|
2023-02-17 |
2023-02-16 |
S
Sale
|
Sherman Matthew L
EVP & Chief Medical Officer
Officer
|
971
-1.1%
15.10
14,661
USD
|
971
-1.1%
|
15.10
|
14,661
USD
|
|
|
2023-02-17 |
2023-02-16 |
S
Sale
|
Pitman Jama
See Remarks
Officer
|
1,159
-2.5%
15.10
17,500
USD
|
1,159
-2.5%
|
15.10
|
17,500
USD
|
|
|
2023-02-16 |
2023-02-14 |
PS
Planned sale
|
Hoerter Steven L.
President and CEO
Executive Director
|
30,045
-80.0%
16.00
480,720
USD
|
30,045
-80.0%
|
16.00
|
480,720
USD
|
|
|
2023-01-24 |
2023-01-24 |
B
Purchase
|
Brightstar Associates LLC
Major owner
|
1,666,666
+9.2%
18.00
29,999,988
USD
|
1,666,666
+9.2%
|
18.00
|
29,999,988
USD
|
|
|
2023-01-19 |
2023-01-17 |
PS
Planned sale
|
Sherman Matthew L
EVP & Chief Medical Officer
Officer
|
2,403
-3.2%
21.24
51,043
USD
|
2,403
-3.2%
|
21.24
|
51,043
USD
|
|
|
2023-01-19 |
2023-01-17 |
PS
Planned sale
|
Martin Daniel C.
Chief Commercial Officer
Officer
|
1,603
-3.2%
21.24
34,050
USD
|
1,603
-3.2%
|
21.24
|
34,050
USD
|
|
|
2023-01-19 |
2023-01-17 |
S
Sale
|
Kelly Thomas Patrick
Chief Financial Officer
Officer
|
2,403
-5.2%
21.24
51,043
USD
|
2,403
-5.2%
|
21.24
|
51,043
USD
|
|
|
2023-01-19 |
2023-01-17 |
S
Sale
|
Pitman Jama
See Remarks
Officer
|
1,603
-4.4%
21.24
34,050
USD
|
1,603
-4.4%
|
21.24
|
34,050
USD
|
|
|
2023-01-19 |
2023-01-17 |
S
Sale
|
Flynn Daniel Lee
Chief Scientific Officer
Officer
|
2,403
-5.2%
21.24
51,043
USD
|
2,403
-5.2%
|
21.24
|
51,043
USD
|
|
|
2022-10-05 |
2022-10-03 |
S
Sale
|
Sherman Matthew L
EVP & Chief Medical Officer
Officer
|
2,587
-3.4%
18.73
48,455
USD
|
2,587
-3.4%
|
18.73
|
48,455
USD
|
|
|
2022-06-21 |
2022-06-16 |
S
Sale
|
Kelly Thomas Patrick
Chief Financial Officer
Officer
|
1,768
-3.7%
10.75
19,006
USD
|
1,768
-3.7%
|
10.75
|
19,006
USD
|
|
|
2022-06-21 |
2022-06-16 |
S
Sale
|
Flynn Daniel Lee
Chief Scientific Officer
Officer
|
1,768
-3.7%
10.75
19,006
USD
|
1,768
-3.7%
|
10.75
|
19,006
USD
|
|
|
2022-06-21 |
2022-06-16 |
PS
Planned sale
|
Sherman Matthew L
EVP & Chief Medical Officer
Officer
|
1,768
-2.2%
10.75
19,006
USD
|
1,768
-2.2%
|
10.75
|
19,006
USD
|
|
|
2022-06-21 |
2022-06-16 |
PS
Planned sale
|
Martin Daniel C.
Chief Commercial Officer
Officer
|
1,311
-2.6%
10.75
14,093
USD
|
1,311
-2.6%
|
10.75
|
14,093
USD
|
|
|
2022-06-21 |
2022-06-16 |
S
Sale
|
Pitman Jama
See Remarks
Officer
|
1,298
-3.4%
10.75
13,954
USD
|
1,298
-3.4%
|
10.75
|
13,954
USD
|
|
|
2022-04-29 |
2022-04-29 |
B
Purchase
|
Brightstar Associates LLC
Major owner
|
1,478,978
+8.9%
10.00
14,789,780
USD
|
1,478,978
+8.9%
|
10.00
|
14,789,780
USD
|
|
|
2022-02-18 |
2022-02-16 |
S
Sale
|
Sherman Matthew L
EVP & Chief Medical Officer
Officer
|
984
-1.3%
9.05
8,905
USD
|
984
-1.3%
|
9.05
|
8,905
USD
|
|
|
2022-02-18 |
2022-02-16 |
S
Sale
|
Martin Daniel C.
Chief Commercial Officer
Officer
|
1,146
-2.3%
9.05
10,371
USD
|
1,146
-2.3%
|
9.05
|
10,371
USD
|
|
|
2022-02-18 |
2022-02-16 |
S
Sale
|
Flynn Daniel Lee
Chief Scientific Officer
Officer
|
1,366
-2.8%
9.05
12,362
USD
|
1,366
-2.8%
|
9.05
|
12,362
USD
|
|
|
2022-02-18 |
2022-02-16 |
S
Sale
|
Kelly Thomas Patrick
Chief Financial Officer
Officer
|
1,368
-2.8%
9.05
12,380
USD
|
1,368
-2.8%
|
9.05
|
12,380
USD
|
|
|
2022-02-18 |
2022-02-16 |
S
Sale
|
Pitman Jama
See Remarks
Officer
|
1,146
-2.9%
9.05
10,371
USD
|
1,146
-2.9%
|
9.05
|
10,371
USD
|
|
|
2021-10-06 |
2021-10-04 |
PS
Planned sale
|
Sherman Matthew L
EVP & Chief Medical Officer
Officer
|
2,659
-5.5%
33.17
88,199
USD
|
2,659
-5.5%
|
33.17
|
88,199
USD
|
|
|
2021-05-05 |
2021-05-03 |
PS
Planned sale
|
Taylor Michael Douglas
Non-Executive Director
|
300
-100.0%
46.75
14,025
USD
|
300
-100.0%
|
46.75
|
14,025
USD
|
|
|
2021-05-05 |
2021-05-03 |
PS
Planned sale
|
Taylor Michael Douglas
Non-Executive Director
|
7,700
-96.2%
46.07
354,718
USD
|
7,700
-96.2%
|
46.07
|
354,718
USD
|
|
|
2021-04-21 |
2021-04-20 |
PS
Planned sale
|
Bristol James Arthur
Non-Executive Director
|
1,700
-100.0%
45.60
77,514
USD
|
1,700
-100.0%
|
45.60
|
77,514
USD
|
|
|
2021-04-21 |
2021-04-19 |
PS
Planned sale
|
Bristol James Arthur
Non-Executive Director
|
1,300
-100.0%
46.66
60,662
USD
|
1,300
-100.0%
|
46.66
|
60,662
USD
|
|
|
2021-04-21 |
2021-04-19 |
PS
Planned sale
|
Bristol James Arthur
Non-Executive Director
|
4,000
-75.5%
46.13
184,518
USD
|
4,000
-75.5%
|
46.13
|
184,518
USD
|
|
|
2021-04-14 |
2021-04-12 |
PS
Planned sale
|
Bristol James Arthur
Non-Executive Director
|
5,217
-100.0%
44.09
230,040
USD
|
5,217
-100.0%
|
44.09
|
230,040
USD
|
|
|
2021-04-14 |
2021-04-12 |
PS
Planned sale
|
Bristol James Arthur
Non-Executive Director
|
9,483
-64.5%
43.70
414,370
USD
|
9,483
-64.5%
|
43.70
|
414,370
USD
|
|
|
2021-04-06 |
2021-04-01 |
PS
Planned sale
|
Taylor Michael Douglas
Non-Executive Director
|
906
-100.0%
46.72
42,328
USD
|
906
-100.0%
|
46.72
|
42,328
USD
|
|
|
2021-04-06 |
2021-04-01 |
PS
Planned sale
|
Taylor Michael Douglas
Non-Executive Director
|
4,994
-84.6%
45.69
228,169
USD
|
4,994
-84.6%
|
45.69
|
228,169
USD
|
|
|
2021-04-06 |
2021-04-01 |
PS
Planned sale
|
Taylor Michael Douglas
Non-Executive Director
|
2,100
-26.2%
44.80
94,074
USD
|
2,100
-26.2%
|
44.80
|
94,074
USD
|
|
|
2021-03-03 |
2021-03-01 |
PS
Planned sale
|
Taylor Michael Douglas
Non-Executive Director
|
1,104
-100.0%
44.68
49,324
USD
|
1,104
-100.0%
|
44.68
|
49,324
USD
|
|
|
2021-03-03 |
2021-03-01 |
PS
Planned sale
|
Taylor Michael Douglas
Non-Executive Director
|
6,896
-86.2%
43.94
302,983
USD
|
6,896
-86.2%
|
43.94
|
302,983
USD
|
|
|
2021-02-18 |
2021-02-16 |
S
Sale
|
Sherman Matthew L
EVP & Chief Medical Officer
Officer
|
132
-0.4%
48.87
6,451
USD
|
132
-0.4%
|
48.87
|
6,451
USD
|
|
|
2021-02-18 |
2021-02-16 |
S
Sale
|
Flynn Daniel Lee
Chief Scientific Officer
Officer
|
508
-7.2%
48.87
24,826
USD
|
508
-7.2%
|
48.87
|
24,826
USD
|
|
|
2021-02-18 |
2021-02-16 |
S
Sale
|
Kelly Thomas Patrick
Chief Financial Officer
Officer
|
524
-7.4%
48.87
25,608
USD
|
524
-7.4%
|
48.87
|
25,608
USD
|
|
|
2021-02-03 |
2021-02-01 |
PS
Planned sale
|
Taylor Michael Douglas
Non-Executive Director
|
800
-100.0%
45.96
36,770
USD
|
800
-100.0%
|
45.96
|
36,770
USD
|
|
|
2021-02-03 |
2021-02-01 |
PS
Planned sale
|
Taylor Michael Douglas
Non-Executive Director
|
4,518
-85.0%
45.64
206,188
USD
|
4,518
-85.0%
|
45.64
|
206,188
USD
|
|
|
2021-02-03 |
2021-02-01 |
PS
Planned sale
|
Taylor Michael Douglas
Non-Executive Director
|
2,682
-33.5%
44.34
118,915
USD
|
2,682
-33.5%
|
44.34
|
118,915
USD
|
|
|
2021-01-20 |
2021-01-15 |
PS
Planned sale
|
Bristol James Arthur
Non-Executive Director
|
600
-100.0%
51.11
30,666
USD
|
600
-100.0%
|
51.11
|
30,666
USD
|
|
|
2021-01-20 |
2021-01-15 |
PS
Planned sale
|
Bristol James Arthur
Non-Executive Director
|
6,400
-91.4%
50.21
321,373
USD
|
6,400
-91.4%
|
50.21
|
321,373
USD
|
|
|
2021-01-06 |
2021-01-04 |
PS
Planned sale
|
Taylor Michael Douglas
Non-Executive Director
|
2,794
-100.0%
57.37
160,294
USD
|
2,794
-100.0%
|
57.37
|
160,294
USD
|
|
|
2021-01-06 |
2021-01-04 |
PS
Planned sale
|
Taylor Michael Douglas
Non-Executive Director
|
8,517
-75.3%
56.73
483,175
USD
|
8,517
-75.3%
|
56.73
|
483,175
USD
|
|
